Medicina de Familia-SEMERGEN最新文献

英文中文

Análisis de características demográficas, de salud y adherencia a la dieta mediterránea en mujeres embarazadas. Cuestionario MEDAS

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-08 DOI: 10.1016/j.semerg.2025.102454

B. López Villalba , B. Marcos Puig , A. García Belinchón , M. Morales-Suarez-Varela

Objective

To identify differences in adherence to the Mediterranean diet and to evaluate the influence of sociodemographic, lifestyle and clinical characteristics associated with the presentation of pathologies during pregnancy.

Material and methods

Nested case-control study carried out at the Hospital Universitario y Politécnico La Fe of Valencia with women admitted to the obstetrics ward who had given birth between 10/06/2024 and 25/07/2024. The instruments used included sociodemographic and lifestyle questionnaires, the MEDAS questionnaire and the electronic medical record.

Results

101 women with a mean age of 32 years participated. Adherence to the MEDAS questionnaire was good in 81.2%, medium in 12.9% and low in 5.9%. Women with good adherence had a higher mean age, a predominance of European origin, a lower BMI at the end of pregnancy, a higher educational level, and a higher intake of folic acid and iron supplements. Regarding pregnancy and delivery characteristics, the presence of glucose problems was more common in women with other pathology, but the biochemical parameters analyzed did not show a robust association with the presence of pathology during pregnancy. Finally, the characteristics of the newborn showed no significant differences between groups.

Conclusions

The implementation of nutritional strategies aimed at increasing adherence to the Mediterranean diet could have a positive impact on the health of pregnant women, especially in relation to the consumption of essential supplements.

{"title":"Análisis de características demográficas, de salud y adherencia a la dieta mediterránea en mujeres embarazadas. Cuestionario MEDAS","authors":"B. López Villalba , B. Marcos Puig , A. García Belinchón , M. Morales-Suarez-Varela","doi":"10.1016/j.semerg.2025.102454","DOIUrl":"10.1016/j.semerg.2025.102454","url":null,"abstract":"<div><h3>Objective</h3><div>To identify differences in adherence to the Mediterranean diet and to evaluate the influence of sociodemographic, lifestyle and clinical characteristics associated with the presentation of pathologies during pregnancy.</div></div><div><h3>Material and methods</h3><div>Nested case-control study carried out at the Hospital Universitario y Politécnico La Fe of Valencia with women admitted to the obstetrics ward who had given birth between 10/06/2024 and 25/07/2024. The instruments used included sociodemographic and lifestyle questionnaires, the MEDAS questionnaire and the electronic medical record.</div></div><div><h3>Results</h3><div>101 women with a mean age of 32 years participated. Adherence to the MEDAS questionnaire was good in 81.2%, medium in 12.9% and low in 5.9%. Women with good adherence had a higher mean age, a predominance of European origin, a lower BMI at the end of pregnancy, a higher educational level, and a higher intake of folic acid and iron supplements. Regarding pregnancy and delivery characteristics, the presence of glucose problems was more common in women with other pathology, but the biochemical parameters analyzed did not show a robust association with the presence of pathology during pregnancy. Finally, the characteristics of the newborn showed no significant differences between groups.</div></div><div><h3>Conclusions</h3><div>The implementation of nutritional strategies aimed at increasing adherence to the Mediterranean diet could have a positive impact on the health of pregnant women, especially in relation to the consumption of essential supplements.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 5","pages":"Article 102454"},"PeriodicalIF":0.9,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Asociación entre las variables sociodemográficas, los hábitos saludables y el estrés con síndrome metabólico: un estudio descriptivo y transversal

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-08 DOI: 10.1016/j.semerg.2025.102455

Á.A. López-González , E. Martínez-Almoyna Rifá , H. Paublini Oliveira , C. Martorell Sánchez , P.J. Tárraga López , J.I. Ramírez-Manent

Introduction

Metabolic syndrome (MS) is a pathological condition that encompasses various cardiometabolic risk factors, such as obesity, dyslipidemia, hyperglycemia, and elevated blood pressure levels. It is considered a multifactorial pathological condition. The aim of this study is to assess how variables such as age, sex, socioeconomic status, tobacco and alcohol consumption, physical activity, adherence to the Mediterranean diet, and stress are associated with the prevalence of MS, determined using two different criteria.

Materials and Methods

This is a descriptive, cross-sectional study conducted on 24,224 Spanish workers, evaluating the association between sociodemographic variables, health habits, and stress with MS, determined using two criteria: the National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP-III), and the International Diabetes Federation (IDF).

Results

All the variables analyzed showed an association with the presence of MS when applying both criteria. Among them, the variables with the strongest association were age: odds ratio 5.55 (95% CI: 4.80-6.30) for MS using the NCEP ATP-III criteria and 6.71 (95% CI: 5.30-8.13) for IDF criteria; and type of job: odds ratio 3.42 (95% CI: 2.95-3.90) for NCEP ATP-III and 3.57 (95% CI: 3.12-4.03) for IDF.

Conclusions

The profile of an individual at higher risk of developing MS under both criteria would be an older male, manual laborer, smoker, habitual alcohol consumer, sedentary, with low adherence to the Mediterranean diet, and experiencing high levels of stress.

{"title":"Asociación entre las variables sociodemográficas, los hábitos saludables y el estrés con síndrome metabólico: un estudio descriptivo y transversal","authors":"Á.A. López-González , E. Martínez-Almoyna Rifá , H. Paublini Oliveira , C. Martorell Sánchez , P.J. Tárraga López , J.I. Ramírez-Manent","doi":"10.1016/j.semerg.2025.102455","DOIUrl":"10.1016/j.semerg.2025.102455","url":null,"abstract":"<div><h3>Introduction</h3><div>Metabolic syndrome (MS) is a pathological condition that encompasses various cardiometabolic risk factors, such as obesity, dyslipidemia, hyperglycemia, and elevated blood pressure levels. It is considered a multifactorial pathological condition. The aim of this study is to assess how variables such as age, sex, socioeconomic status, tobacco and alcohol consumption, physical activity, adherence to the Mediterranean diet, and stress are associated with the prevalence of MS, determined using two different criteria.</div></div><div><h3>Materials and Methods</h3><div>This is a descriptive, cross-sectional study conducted on 24,224 Spanish workers, evaluating the association between sociodemographic variables, health habits, and stress with MS, determined using two criteria: the National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP-III), and the International Diabetes Federation (IDF).</div></div><div><h3>Results</h3><div>All the variables analyzed showed an association with the presence of MS when applying both criteria. Among them, the variables with the strongest association were age: odds ratio 5.55 (95% CI: 4.80-6.30) for MS using the NCEP ATP-III criteria and 6.71 (95% CI: 5.30-8.13) for IDF criteria; and type of job: odds ratio 3.42 (95% CI: 2.95-3.90) for NCEP ATP-III and 3.57 (95% CI: 3.12-4.03) for IDF.</div></div><div><h3>Conclusions</h3><div>The profile of an individual at higher risk of developing MS under both criteria would be an older male, manual laborer, smoker, habitual alcohol consumer, sedentary, with low adherence to the Mediterranean diet, and experiencing high levels of stress.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 6","pages":"Article 102455"},"PeriodicalIF":0.9,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

El valor estratégico de la medicina rural: Declaración de Úbeda

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-08 DOI: 10.1016/j.semerg.2025.102453

J.G. Garcia Ballesteros , A. Barquilla García , R.M. Micó-Pérez , M. Jiménez de la Cruz , M.A. Prieto Díaz , M.J. Cruz Rodríguez , I. Araujo Ramos , C. Manzanares Arnaiz

引用次数: 0

Estado de malnutrición como factor pronóstico de eventos cardiovasculares adversos mayores (MACE) en los pacientes con fibrilación auricular

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-07 DOI: 10.1016/j.semerg.2025.102458

P. Moltó-Balado , J.L. Clua-Espuny , S. Reverté-Villarroya , M.T. Balado-Albiol , M. García-Olcina , A. Simeó-Monzó , A. Serra-Garcia , J. Canela-Royo

Objective

To examine nutritional status among patients with atrial fibrillation (AF) and its relationship with major adverse cardiovascular events (MACE), and to determine whether nutritional status is a risk factor for MACE in patients with AF.

Material and methods

Observational, retrospective, community-based study (n = 40,297) aged 65-95 years in Terres de l’Ebre (Catalonia, Spain) between 2015 and 2021. A total of 2,574 patients with a diagnosis of AF were included. The CONUT scale was used to assess nutritional status and Cox regression analyses were performed.

Results

67.91% of AF patients developed MACE. Malnutrition as assessed by the CONUT scale was significantly higher in AF patients who developed MACE (P < .001). Malnutrition doubled the risk of MACE and was identified as a prognostic factor (HR: 1.06; 95% CI: 1.04-1.08; P < .001).

Conclusions

Malnutrition is a prognostic factor for MACE in AF patients. Poorer nutritional status doubles the risk of MACE.

{"title":"Estado de malnutrición como factor pronóstico de eventos cardiovasculares adversos mayores (MACE) en los pacientes con fibrilación auricular","authors":"P. Moltó-Balado , J.L. Clua-Espuny , S. Reverté-Villarroya , M.T. Balado-Albiol , M. García-Olcina , A. Simeó-Monzó , A. Serra-Garcia , J. Canela-Royo","doi":"10.1016/j.semerg.2025.102458","DOIUrl":"10.1016/j.semerg.2025.102458","url":null,"abstract":"<div><h3>Objective</h3><div>To examine nutritional status among patients with atrial fibrillation (AF) and its relationship with major adverse cardiovascular events (MACE), and to determine whether nutritional status is a risk factor for MACE in patients with AF.</div></div><div><h3>Material and methods</h3><div>Observational, retrospective, community-based study (n=40,297) aged 65-95years in Terres de l’Ebre (Catalonia, Spain) between 2015 and 2021. A total of 2,574 patients with a diagnosis of AF were included. The CONUT scale was used to assess nutritional status and Cox regression analyses were performed.</div></div><div><h3>Results</h3><div>67.91% of AF patients developed MACE. Malnutrition as assessed by the CONUT scale was significantly higher in AF patients who developed MACE (<em>P</em>   .001).</div></div><div><h3>Conclusions</h3><div>Malnutrition is a prognostic factor for MACE in AF patients. Poorer nutritional status doubles the risk of MACE.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 6","pages":"Article 102458"},"PeriodicalIF":0.9,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lp(a). Lo que sabemos, lo que desconocemos y lo que esperamos

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-07 DOI: 10.1016/j.semerg.2025.102451

A. Moyá Amengual , A. Serrano-Cumplido

There is no doubt that lipoprotein (a) [Lp(a)] is a structurally complex molecule with unique biological functions. It plays an important role in the inflammatory process through multiple mechanisms, contributes to endothelial dysfunction, activation of monocytes, macrophages and proliferation of smooth muscle cells, and promotes the development of atherosclerotic cardiovascular disease (ASCVD). It is important to point out the complex bidirectional relationship between Lp(a) and inflammation, influencing one another and even exerting anti-inflammatory effects in certain situations. Likewise, Lp(a) can favor the development of heart valve disease, especially of the aortic valve.

Numerous publications emphasize the need to determine Lp(a) levels in the population at least once in life and possible strategies to mitigate the risk of ASCVD generated by high Lp(a) levels. However, doubts or lack of knowledge persist about the need to measure this parameter, either due to the uncertainty of how to manage patients with high levels of Lp(a), due to insufficient knowledge about its physiological function or because its levels persist unchanged, to a large extent, throughout life as the genetic character of this molecule takes precedence. On the other hand, there are still no specific approved therapies that reduce its levels and arouse sufficient interest for its management. However, many societies, such as the European Society of Cardiology (SEC) or the Spanish Society of Atherosclerosis (SEA), raise the need to determine Lp(a) and intensive management of cardiovascular risk factors in patients with high Lp(a) levels along with therapies that mitigate the associated ASCVD risk. Likewise, the identification of high levels of Lp(a) offers the opportunity to screen family members, better control of cardiovascular risk and the possibility of developing clinical trials that profile individual and population risk that allow for more personalized actions.

{"title":"Lp(a). Lo que sabemos, lo que desconocemos y lo que esperamos","authors":"A. Moyá Amengual , A. Serrano-Cumplido","doi":"10.1016/j.semerg.2025.102451","DOIUrl":"10.1016/j.semerg.2025.102451","url":null,"abstract":"<div><div>There is no doubt that lipoprotein(a) [Lp(a)] is a structurally complex molecule with unique biological functions. It plays an important role in the inflammatory process through multiple mechanisms, contributes to endothelial dysfunction, activation of monocytes, macrophages and proliferation of smooth muscle cells, and promotes the development of atherosclerotic cardiovascular disease (ASCVD). It is important to point out the complex bidirectional relationship between Lp(a) and inflammation, influencing one another and even exerting anti-inflammatory effects in certain situations. Likewise, Lp(a) can favor the development of heart valve disease, especially of the aortic valve.</div><div>Numerous publications emphasize the need to determine Lp(a) levels in the population at least once in life and possible strategies to mitigate the risk of ASCVD generated by high Lp(a) levels. However, doubts or lack of knowledge persist about the need to measure this parameter, either due to the uncertainty of how to manage patients with high levels of Lp(a), due to insufficient knowledge about its physiological function or because its levels persist unchanged, to a large extent, throughout life as the genetic character of this molecule takes precedence. On the other hand, there are still no specific approved therapies that reduce its levels and arouse sufficient interest for its management. However, many societies, such as the European Society of Cardiology (SEC) or the Spanish Society of Atherosclerosis (SEA), raise the need to determine Lp(a) and intensive management of cardiovascular risk factors in patients with high Lp(a) levels along with therapies that mitigate the associated ASCVD risk. Likewise, the identification of high levels of Lp(a) offers the opportunity to screen family members, better control of cardiovascular risk and the possibility of developing clinical trials that profile individual and population risk that allow for more personalized actions.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 7","pages":"Article 102451"},"PeriodicalIF":0.9,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fisiología del envejecimiento: Actualización y perspectiva genética

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-07 DOI: 10.1016/j.semerg.2025.102452

D.S. López-Delgado , G.L. Chapues-Andrade , C.A. Narváez , J.C. Zambrano Santacruz , C.Y. Rosero-Galindo

Aging is a physiological process resulting from the accumulation of molecular and cellular damage over time, leading to a gradual decline in overall physical and mental health. Throughout this temporal continuum, various physiological alterations occur in the organism, modifying the individual's response to multiple stimuli and adverse factors. At the same time, an increasingly significant manifestation of genetic modifications is observed, which are intrinsically interconnected with the dynamics of these adaptive processes. The geriatric population is characterized by its high prevalence in hospital settings, particularly in critical care units, where admissions from this group account for nearly 50% of total admissions. Thus, acquiring and updating knowledge is relevant and necessary to ensure a more effective therapeutic approach for geriatric patients.

引用次数: 0

Utilidad de la ecografía abdominal en el estudio etiológico de la enfermedad tromboembólica venosa idiopática como método diagnóstico de la neoplasia oculta

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-06 DOI: 10.1016/j.semerg.2025.102449

C. Idoate Ortueta , L. del Campo del Val , N. Ruiz-Giménez Arrieta , C. Suárez Fernández , A. Friera Reyes , P. Rodríguez Carnero

Purpose

To determine the sensibility of abdominal ultrasound (US) in the screening of occult cancer in patients with idiopathic venous thromboembolism (iVTE).

To evaluate its sensitivity and specificity in different subgroups of patients with iVTE, in order to detect potential beneficiaries in whom the abdominal US screening may have greater diagnostic benefit.

Descriptive analysis of the use of abdominal US in these patients, and evaluation of its impact on their management.

Material and methods

We retrospectively searched all patients with confirmed iVTE (by Doppler-US, by CT angiography or V/Q scintigraphy) between 2011-2014, which had been performed an abdominal US for screening of occult malignancy as part as their aetiology study of VTE. As reference we set a follow-up period of 2 years.

Results

280 patients were found, and 209 were included after inclusion and exclusion criteria were applied. Abdominal US was positive for malignancy in 7 patients (3.3%). The sensitivity and specificity for cancer detection were 43.75% and 99.48%, respectively. Cancer was found in 16 patients in the 2-year follow-up (7.6%). No significant differences were found in the different subgroups of patients. Nevertheless, 28 patients (13.4%) were diagnosed of other cause of VTE during aetiology study, mainly hypercoagulability disorders.

Conclusions

Abdominal US for screening of occult malignancy in patients with iVTE is a very specific test but has low sensitivity, which compromises its utility as a routine screening test in these patients. Its use could be optimised by performing it only in selected subgroups of patients that need to be established in future research.

{"title":"Utilidad de la ecografía abdominal en el estudio etiológico de la enfermedad tromboembólica venosa idiopática como método diagnóstico de la neoplasia oculta","authors":"C. Idoate Ortueta , L. del Campo del Val , N. Ruiz-Giménez Arrieta , C. Suárez Fernández , A. Friera Reyes , P. Rodríguez Carnero","doi":"10.1016/j.semerg.2025.102449","DOIUrl":"10.1016/j.semerg.2025.102449","url":null,"abstract":"<div><h3>Purpose</h3><div>To determine the sensibility of abdominal ultrasound (US) in the screening of occult cancer in patients with idiopathic venous thromboembolism (iVTE).</div><div>To evaluate its sensitivity and specificity in different subgroups of patients with iVTE, in order to detect potential beneficiaries in whom the abdominal US screening may have greater diagnostic benefit.</div><div>Descriptive analysis of the use of abdominal US in these patients, and evaluation of its impact on their management.</div></div><div><h3>Material and methods</h3><div>We retrospectively searched all patients with confirmed iVTE (by Doppler-US, by CT angiography or V/Q scintigraphy) between 2011-2014, which had been performed an abdominal US for screening of occult malignancy as part as their aetiology study of VTE. As reference we set a follow-up period of 2years.</div></div><div><h3>Results</h3><div>280 patients were found, and 209 were included after inclusion and exclusion criteria were applied. Abdominal US was positive for malignancy in 7 patients (3.3%). The sensitivity and specificity for cancer detection were 43.75% and 99.48%, respectively. Cancer was found in 16 patients in the 2-year follow-up (7.6%). No significant differences were found in the different subgroups of patients. Nevertheless, 28 patients (13.4%) were diagnosed of other cause of VTE during aetiology study, mainly hypercoagulability disorders.</div></div><div><h3>Conclusions</h3><div>Abdominal US for screening of occult malignancy in patients with iVTE is a very specific test but has low sensitivity, which compromises its utility as a routine screening test in these patients. Its use could be optimised by performing it only in selected subgroups of patients that need to be established in future research.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 5","pages":"Article 102449"},"PeriodicalIF":0.9,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143297560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Encuesta sobre los conocimientos de la enfermedad hepática metabólica (EHMet) entre los médicos de Atención Primaria en España

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-02-04 DOI: 10.1016/j.semerg.2025.102448

C. Expósito Martínez , S. Fernández Jorde , A.B. García Garrido , N. Fontanillas Garmilla , J. Crespo García

Objective

Improving the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in Primary Care requires a good knowledge of the disease. This study evaluated the knowledge of biomarkers and comorbidities associated with the disease among Primary Care Physicians (PCPs), the resources available for diagnosis, and the relationship with hepatologists.

Materials and methods

Cross-sectional study based on an anonymous email survey sent to PCPs actively practicing at the time of distribution. Retired professionals were excluded. The survey comprised 29 questions grouped into 3 sections: 1. Sociodemographic characteristics, 2. Relationship with the gastroenterology department, 3. Diagnosis and management of MAFLD.

Results

A total of 362 responses were received (10.23% participation). Of the respondents, 64.2% were women, and the most participative age group was 50-59 (29.4%). Cantabria, Catalonia, Andalusia, Castilla-León and Madrid were the regions with the highest response rates. 81.5% of PCPs did not have protocols for diagnosis and management, and while two-thirds were familiar with the Fib-4 marker, only half used it. Having protocols increased the use of Fib-4 (OR 4.41; 95%CI 1.68-11.53). A total of 81.5% recognized the importance of extrahepatic comorbidities, and 92% actively screened for cardiovascular risk factors. Elastography was considered useful by 58.7%, but only 11% had access to it. 72% of PCPs had no relationship with specialists, although 60% had access to a Hepatology Unit.

Conclusions

It is necessary to improve knowledge of MAFLD, strengthen collaboration between care levels, and establish standardized management protocols.

{"title":"Encuesta sobre los conocimientos de la enfermedad hepática metabólica (EHMet) entre los médicos de Atención Primaria en España","authors":"C. Expósito Martínez , S. Fernández Jorde , A.B. García Garrido , N. Fontanillas Garmilla , J. Crespo García","doi":"10.1016/j.semerg.2025.102448","DOIUrl":"10.1016/j.semerg.2025.102448","url":null,"abstract":"<div><h3>Objective</h3><div>Improving the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in Primary Care requires a good knowledge of the disease. This study evaluated the knowledge of biomarkers and comorbidities associated with the disease among Primary Care Physicians (PCPs), the resources available for diagnosis, and the relationship with hepatologists.</div></div><div><h3>Materials and methods</h3><div>Cross-sectional study based on an anonymous email survey sent to PCPs actively practicing at the time of distribution. Retired professionals were excluded. The survey comprised 29 questions grouped into 3sections: 1. Sociodemographic characteristics, 2. Relationship with the gastroenterology department, 3. Diagnosis and management of MAFLD.</div></div><div><h3>Results</h3><div>A total of 362 responses were received (10.23% participation). Of the respondents, 64.2% were women, and the most participative age group was 50-59 (29.4%). Cantabria, Catalonia, Andalusia, Castilla-León and Madrid were the regions with the highest response rates. 81.5% of PCPs did not have protocols for diagnosis and management, and while two-thirds were familiar with the Fib-4 marker, only half used it. Having protocols increased the use of Fib-4 (OR 4.41; 95%<span>C</span>I 1.68-11.53). A total of 81.5% recognized the importance of extrahepatic comorbidities, and 92% actively screened for cardiovascular risk factors. Elastography was considered useful by 58.7%, but only 11% had access to it. 72% of PCPs had no relationship with specialists, although 60% had access to a Hepatology Unit.</div></div><div><h3>Conclusions</h3><div>It is necessary to improve knowledge of MAFLD, strengthen collaboration between care levels, and establish standardized management protocols.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 5","pages":"Article 102448"},"PeriodicalIF":0.9,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143144915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reto diagnóstico: enfermedad de Creutzfeldt-Jakob esporádico

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-01-28 DOI: 10.1016/j.semerg.2024.102425

M. Bosi, S. Reviriego Mazaira, A. Angulo Morales

引用次数: 0

Utilidad de la ecografía a pie de cama en Atención Primaria para el diagnóstico del tromboembolismo paucisintomático: a propósito de un caso

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-01-22 DOI: 10.1016/j.semerg.2024.102432

D. Martín-Enguix , C. Marín López , M. Guisasola Cárdenas , R. Quintana Prego , A. Segura-Grau

引用次数: 0

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Medicina de Familia-SEMERGEN

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀